(NewsDirect)
e-Therapeutics PLC (AIM:ETX OTCQX:ETXPF)CEO Ali Mortazavi speaks to Thomas Warner following the release of thecomputational biology and chemistry company's full year resultsfor 2022. Mortazavi says that it was a "tricky year for thebiotechnology sector as a whole" but that eTherapeutics has shown"remarkable resilience."
He goes on to highlight theopportunity being presented to the company by the advent of largelanguage models (LLMs) and GPT-4, saying that he's never beforeseen a technology "blindside the world" to such anextent.
Contact Details
Proactive UKLtd
Proactive UK Ltd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.